Enhancing the Treatment of High-Risk Non-Muscle-Invasive Bladder Cancer With Immunotherapy-Based Regimens

Name: Enhancing the Treatment of High-Risk Non-Muscle-Invasive Bladder Cancer With Immunotherapy-Based Regimens
Start: 2024-05-13T08:00:00-05:00
End: 2024-05-13T17:00:00-05:00
Location: Enduring Material

Unavailable

Enduring Material

Medscape, LLC

1.25 AMA

Related events

It seems we can't find what you're looking for.

For more than 30 years, MECOP has been an ACCME-accredited provider of continuing medical education for physicians.

Enhancing the Treatment of High-Risk Non-Muscle-Invasive Bladder Cancer With Immunotherapy-Based Regimens

Enhancing the Treatment of High-Risk Non-Muscle-Invasive Bladder Cancer With Immunotherapy-Based Regimens

Related events

Upcoming Events

Quick Links

Contact Us